Jordan Levy joined the Board of Core Scientific as an Independent Director in January 2024, serving on the Nominating and Corporate Governance Committee. He is non-executive Chairman of Synacor (Nasdaq: SYNC) and Director of COKeM International Ltd. Levy co-founded Z80 Labs, a startup incubator in Buffalo, and serves as Chairman of the 43North global business plan competition.
Levy's venture capital experience includes investments in Buddy Media (acquired by Salesforce.com) and Huffington Post (acquired by AOL). His prior roles include Chairman of the Erie Canal Harbor Development Corporation, membership on the Upstate Regional Advisory Board for the Federal Reserve Bank of New York, trustee of the University of Buffalo Foundation, nine years as a trustee of the Albright-Knox Art Gallery, and past President of the Jewish Federation of Greater Buffalo. He holds a B.A. in Political Science from State University of New York at Buffalo.
Biography extracted from Core Scientific DEF 14A filed 2025-03-28 View cached copy (2026-08-31)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Director | 2024-01 → present (2y 8mo) | 6 |
Show 6 underlying filings | |||
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 325,462 | $997.0K | - | $0 | ↑ Invested $997.0K | 6 | $5.58M | $0 |
| 2026 | 18,575 | $0 | - | $0 | Flat | 1 | $318.4K | $0 |
| 2025 | 82,948 | $500.5K | - | $0 | ↑ Invested $500.5K | 2 | $1.42M | $0 |
| 2024 | 223,939 | $496.5K | - | $0 | ↑ Invested $496.5K | 3 | $3.84M | $0 |
| 2024-Q2 | 175,239 | $0 | - | $0 | Flat | 2 | $3.00M | $0 |
| 2024-Q3 | 48,700 | $496.5K | - | $0 | ↑ Invested $496.5K | 1 | $834.7K | $0 |
| 2025-Q1 | 82,948 | $500.5K | - | $0 | ↑ Invested $500.5K | 2 | $1.42M | $0 |
| 2026-Q1 | 18,575 | $0 | - | $0 | Flat | 1 | $318.4K | $0 |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-09-17); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2026-02-04 | Core Scientific | Grant / award / vesting | 18,575 | - | $318.4K |
| 2025-03-06 | Core Scientific | Open-market purchase | 62,500 | $500,506 | $1.07M |
| 2025-01-27 | Core Scientific | Grant / award / vesting | 20,448 | - | $350.5K |
| 2024-08-20 | Core Scientific | Open-market purchase | 48,700 | $496,531 | $834.7K |
| 2024-05-27 | Core Scientific | Grant / award / vesting | 127,446 | - | $2.18M |
| 2024-05-27 | Core Scientific | Grant / award / vesting | 47,793 | - | $819.2K |